Trustfeed Corp (TRFE)

[stervc]

Significant HEME Cannabis & Covid-19 Potential...

I think it is first important for all to do their own research to understand all that I believe is still going on after doing my own research after I emailed the company. The email response from the CEO confirmed to me that they own the contract to close on the huge deal I posted about below:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156652254

Again, I have no time frame although it was good to confirm that what was previously PR-ed is still in effect. Others have emailed the company and confirmed that they are in the process of getting current with their financials. There is also more but let’s talk about this cannabis cultivation piece because I think it is huge.

I have learned and confirmed that they are still under contract to acquire this deal of 37 acres and 15 to 20 Greenhouses of which each one will be 25,000 square feet each per their website. That's a total of 375,000 to 500,000 in total square footage for the property that has been re-zoned for the cultivation of Cannabis:

http://www.healthmedservicesltd.com/marijuana-property-real-estate-investing.html

Hemp and marijuana are both cannabis so for the purpose of what I'm referring, take into consideration that I am not sure to what extent the company is referring to hemp or marijuana when they use the word cannabis. I will presume that they are referring to hemp since I believe it is the cheaper of the two to help to explain that magnitude here with HEME more conservatively.

If HEME closes this deal, they are going to have anywhere from 375,000 to 500,000 in total square footage. Just to get an idea of what kind of value this will add to HEME... Tilray (TLRY) trades on the NASDAQ at $7.00+ per share. Important to note... "Tilray will now have 1.3 million square feet worldwide for production and manufacturing, the company said"... from the link below:
https://www.barrons.com/articles/which-is-better-for-your-early-retirement-strategy-being-a-homeowner-or-a-landlord-51595768402

"Tilray (TLRY:NASDAQ) generates over $166 Million in Revenues from the link below:
https://ir.tilray.com/news-releases/news-release-details/tilray-inc-reports-fourth-quarter-and-full-fiscal-year-2019

Paragon Processing claims to have the largest operating hemp processing facility in the U.S., encompassing 250,000 square feet. The high-security facility, stationed on a 38-acre property, is located 140 miles south of Denver:
https://www.prnewswire.com/news-releases/paragon-processing-the-largest-operating-hemp-processing-facility-in-the-us-now-open-for-business-300908794.html

Another company to go look at to "compare and contrast" to what HEME is building is Innovative Industrial Properties, Inc. (IIPR) which trades on the NYSE at over $93.00+ per share:
https://www.otcmarkets.com/stock/IIPR/profile

My point is that I like the risk for the potential for growth that would exist if HEME was to execute on closing what they are still under contract to acquire in the deal consisting of 37 acres and 15 to 20 Greenhouses of which each one will be 25,000 square feet each per their website that would equate to a total of 375,000 to 500,000 in total square footage for the property that has been re-zoned for the cultivation of Cannabis.

As an extra added addition to what they had previously announced is this piece below...

HEME entered into a Memorandum of Understanding to form a Joint Venture between Advanced Prenatal Therapeutics, Inc. (APT) and a new distribution company, to be formed by HEME to distribute products that have been invented and/or patented by APT:
https://www.otcmarkets.com/stock/HEME/news/HealthMed-Services-Ltd-Announces-Memorandum-Of-Understanding-With-Advanced-Prenatal-Therapeutics-Inc?id=219850

This is huge for a few reasons in my opinion which is another reason why HEME has indicated that they are working on their financials to get current and are still working on their pre-existing operations previously announced on their website.

First, Advanced Prenatal Therapeutics, Inc. (APT) announced that the FDA (U.S. Food and Drug Administration) granted a Breakthrough Device Designation for APT’s Targeted Apheresis Column for Preeclampsia (TAC-PE):
https://www.advancedprenatal.com/copy-of-patent-allowed

FDA Breakthrough Devices Program:
https://www.fda.gov/medical-devices/how-study-and-market-your-device/breakthrough-devices-program


Here are the APT Patents:

https://www.advancedprenatal.com/about-us
• US 20100247650 A1 - Treatment for pre-eclampsia in pregnant women using targeted apheresis

• 62/602,816 - Apheresis to treat high blood pressure in pre-eclampsia and hypertension (patent pending)

• 62/605,128 - Targeted apheresis to remove harmful substances from blood (patent pending)

I think this FDA piece for their newly created division could be something significant that is being talked about worldwide to use as a plasma process to treat the coronavirus to where blood is removed from one's body, properly treated by removing antigens, and then filtered back into one's body.

I had seen this doctor on TV explain this process a little while back. When the plasma is transfused, it provides a passive immunity. The way that we recover from the virus is that our body has an active immunity to it. So when the body detects the virus, we normally react by creating our own antibodies which attacks the virus. The people who are not doing so well is because their immune system can't fight off the virus or their immune system can't build up fast enough to fight off the virus. So this passive immunity will jumpstart their immune system to help them get off the ventilator on their path to recovery.

Read the link below what I previously posted regarding an earlier case study conducted at the infectious disease department, Shenzhen Third People's Hospital, Shenzhen, China, from January 20, 2020, to March 25, 2020 to see how this uncontrolled case series of 5 critically ill patients with COVID-19 and acute respiratory distress syndrome (ARDS), through the administration of convalescent plasma containing neutralizing antibody was followed by an improvement in clinical status. All 5 recovered and 4 of the 5 recovered to start showing almost immediate signs of their recovery:
https://jamanetwork.com/journals/jama/fullarticle/2763983

Before looking at the FDA technology, first understand that the original intent of the FDA technology was used to treat Preeclampsia (TAC-PE) which is also known as Toxemia. The famous Beyonce had Preeclampsia as Advanced Prenatal Therapeutics, Inc. is mentioned within the article:

Beyonce Had Pre-Eclampsia. Doctors Have New Ways to Detect and Treat It
https://www.thedailybeast.com/beyonce-had-pre-eclampsia-doctors-have-new-ways-to-detect-and-treat-it?ref=scroll

Here is the diagram and info of their FDA technology to view:

https://www.advancedprenatal.com/our-technology


https://www.medgadget.com/2019/04/new-device-cleans-blood-to-treat-preeclampsia.html

v/r
Sterling